ARNI Contraindications
I cannot provide contraindications for ARNI (Angiotensin Receptor-Neprilysin Inhibitor) medications based on the evidence provided, as all the evidence relates to anticoagulation therapy in pregnancy, Arnica montana (a herbal supplement), and allergy management—none of which address ARNI medications like sacubitril/valsartan.
Critical Clarification Needed
The evidence provided discusses:
- Anticoagulation guidelines for pregnancy (LMWH, warfarin, heparin, DOACs) 1, 2
- Arnica montana (a homeopathic/herbal product) interactions with warfarin and its toxicity profile 3, 4
- Fondaparinux use in pregnancy 5
- General anticoagulant and antiplatelet drug development 6
- Allergy medications in pregnancy 7
None of this evidence addresses ARNI medications (sacubitril/valsartan, marketed as Entresto), which are used for heart failure management.
If You Meant ARNI (Sacubitril/Valsartan):
The absolute contraindications for ARNI medications typically include:
- Concomitant use with ACE inhibitors (36-hour washout period required)
- History of angioedema related to ACE inhibitors or ARBs
- Pregnancy (teratogenic effects from ARB component)
- Severe hepatic impairment
If You Meant Arnica Montana:
Based on the limited evidence provided, Arnica should be avoided in:
- Patients taking warfarin or anticoagulants due to potential bleeding risk potentiation 3
- Pregnancy due to severe gastroenteritis, cardiac effects, and potential death with ingestion 4
- Individuals with known sesquiterpene lactone allergy (delayed type IV hypersensitivity) 4
Please clarify which medication you are asking about for accurate contraindication information.